GL1X · GenesisL1 explorer

MolNFT v1 · #19408 · protein

Protein aggregation and ALZHEIMER'S disease: crystallographic analysis of the phenomenon. engineered version of the ribosomal protein S6 used as a stable scaffold to study oligomerization.

1QJH · 30S ribosomal protein S6: “Protein aggregation and ALZHEIMER'S disease: crystallographic analysis of the phenomenon. engineered version…”. X-ray diffraction, 1 ligand (MG), 1 pocket (best druggability 0.34). MolNFT v1 #19408 on…

PDB
1QJH
Type
protein
Length
93 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
30S ribosomal protein S6
UniProt
P23370
Ligands
MG
Pockets
1 · best druggability 0.34

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A30S ribosomal protein S6protein9331% helix, 43% strandP23370

Ligands and binding sites

  • MG · Magnesium ion · metal

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1640.340.7718empty

Compared structures

  • 1QJH · Protein Aggregation and Alzheimer's Disease: Crystallographic Analysis of the Phenomenon.… · the same entry in another collection · chain A against A, TM-score 1.00
  • P23370 · AlphaFold monomer V2.0 prediction for 30S ribosomal protein S6 (P23370) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.